Clinical Trial Update: Identification of Neuroinflammation and Neuroimaging Biomarkers Through Data Driven Artificial Intelligence Techniques for Unraveling the Heterogeneity of Aged Subjects at Risk of Dementia and to Better Inform Prevention Strategies [NA]

View source ↗

Summary

A clinical trial exploring neuroinflammation and neuroimaging biomarkers in aged individuals at risk for dementia using AI to understand heterogeneity and infor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment
• Subjective Cognitive Decline

Snippet

Sponsor: IRCCS Fondazione Stella Maris | Conditions: MCI, SCD | NA | Status: RECRUITING